Modulation of the intestinal ecosystem by probiotics and lactulose in children during treatment with ceftriaxone

Current Therapeutic Research - Clinical and Experimental

Volumn 62, Issue 5, 2001, Pages 418-435

  Zoppi, Giuseppe ^a   Cinquetti, Mauro ^a   Benini, Anna ^a   Bonamini, Elettra ^a   Minelli, Elisa Bertazzoni ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

Beta lactamases; Children; Colonic enzymes; Colonic microflora; Intestinal imbalance; Probiotics

Indexed keywords

BIOFLORIN; CEFTRIAXONE; CODEX; LACTULOSE; PROBIOTIC AGENT;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL FLORA; BIFIDOBACTERIUM; COLON FLORA; CONTROLLED STUDY; ECOSYSTEM; ENTEROCOCCUS; ESCHERICHIA COLI; FEMALE; HUMAN; INTESTINE FLORA; LACTOBACILLUS; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION;

BIFIDOBACTERIUM BIFIDUM; ENTEROCOCCUS; ESCHERICHIA COLI; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS BIFIDUS; LACTOBACILLUS CASEI; LACTOBACILLUS RHAMNOSUS; SACCHAROMYCES BOULARDII;

EID: 0034995832     PISSN: 0011393X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0011-393X(01)89006-8     Document Type: Article

References (39)

1. Oral bacteriotherapy in clinical practice. 1. The use of different preparations in infants treated with antibiotics
2. Probiotics and prebiotics in the treatment of infections due to vancomycin-dependent Enterococcus faecalis and of imbalance of the intestinal ecosystem (dysbiosis)
3. Oral bacteriotherapy in clinical practice. II. The use of different preparations in the treatment of acute diarrhoea
4. Successful treatment of relapsing Clostridium difficile colitis with Lactobacillus GG
5. Probiotics in man and animals
6. Bacteriotherapy for chronic relapsing Clostridium difficile colitis with Lactobacillus GG
7. Treatment of recurrent Clostridium difficile colitis with vancomycin and Saccharomyces boulardii
8. Treatment of recurrent Clostridium difficile colitis with Lactobacillus GG
9. Treatment of relapsing Clostridium difficile diarrhea with Lactobacillus GG
10. Yoghurt with Bifidobacterium longum reduces erythromycin-induced gastrointestinal effects
11. Effect of Lactobacillus GG yoghurt in prevention of antibiotic associated diarrhoea
12. A double-blind placebo-controlled study of the efficacy of Lactinex in the prophylaxis of amoxicillin-induced diarrhea
13. Effects of supplements of Bifidobacterium longum and Lactobacillus acidophilus on the intestinal microbiota during administration of clindamycin
14. A human Lactobacillus strain (Lactobacillus casei sp strain GG) promotes recovery from acute diarrhea in children
15. Enhancement of the circulating antibody secreting cell response in human diarrhea by a human Lactobacillus strain
16. Efficacy of Lactobacillus GG as a diarrheal preventive in travelers
17. Plate counting of probiotic products
18. "Probiotic" remedies are not what they seem
19. Effects of Lactobacillus acidophilus and Bifidobacterium bifidum administration on colonic microbiota and its metabolic activity in premenstrual syndrome
20. The intestinal ecosystem in chronic functional constipation
21. Antibiotics and their interaction with intestinal contents
22. β-Lactam antibiotics: Mode of action and bacterial resistance
23. Effect of intramuscular ceftriaxone on aerobic oral and faecal flora of 11 healthy volunteers
24. Bifidogenic factors - Sources, metabolism and applications
25. Lactulose and intestinal microflora in infant nutrition
26. Administration of transgalactooligosaccharides increases fecal Bifidobacteria and modifies colonic fermentation metabolism in healthy humans
27. The association of yoghurt starters with Lactobacillus casei DN 114.001 in fermented milk alters the composition and metabolism of intestinal microflora in germ-free rats and in human flora-associated rats
28. In vitro lactose fermentation by human colonic bacteria is modified by Lactobacillus acidophilus supplementation
29. Probiotics from an immunological point of view
30. Metabolic activities of the gut microflora in relation to cancer
31. The relationship between an increase in beta-lactamase activity after oral administration of three new cephalosporins and protection against intestinal ecological disturbances
32. Lactic acid bacteria and human clinical infection
33. Endocarditis caused by a probiotic lactobacillus. 2nd European Congress Chemother and BICON 7
34. Safety of lactic acid bacteria and their occurrence in human clinical infections
35. Fermented milks with selected intestinal bacteria: A healthy trend in new products
36. Current probiotics - Safety assured?
37. Fungemia with Saccharomyces boulardii in a 1-year-old girl with protracted diarrhea
38. Saccharomyces boulardii for the treatment of Clostridium difficile-associated colitis
39. Vancomycin-dependent Enterococcus faecalis